You have 9 free searches left this month | for more free features.

mRNA-1653

Showing 26 - 50 of 784

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV-2 Trial in United States (mRNA-1283, mRNA-1273, Placebo)

Active, not recruiting
  • SARS-CoV-2
  • mRNA-1283
  • +2 more
  • Chandler, Arizona
  • +4 more
Sep 22, 2022

Relapsed or Refractory Multiple Myeloma Trial in Canada, United States (mRNA-2736)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • mRNA-2736
  • Birmingham, Alabama
  • +12 more
Jun 15, 2023

Methylmalonic Acidemia Trial in Birmingham (mRNA-3705)

Recruiting
  • Methylmalonic Acidemia
  • Toronto, Ontario, Canada
  • +1 more
Dec 20, 2022

Healthy Volunteers Trial in United Kingdom (mRNA-1769, Placebo)

Recruiting
  • Healthy Volunteers
  • mRNA-1769
  • Placebo
  • Bradford, United Kingdom
  • +11 more
Aug 18, 2023

Emergency Department (SPEED)

Not yet recruiting
  • Respiratory Tract Infections
  • +5 more
  • IMX-BVN-4 and IMX-SEV-4
  • (no location specified)
Nov 28, 2022

COVID-19, COVID-19 Immunisation Trial in Decatur, Bethesda, Seattle (mRNA-1273)

Completed
  • COVID-19
  • COVID-19 Immunisation
  • mRNA-1273
  • Decatur, Georgia
  • +2 more
Jan 26, 2023

COVID-19 Infection Trial in Turkey (Taking biological samples (blood) and keeping records with phone calls)

Active, not recruiting
  • COVID-19 Infection
  • Taking biological samples (blood) and keeping records with phone calls
  • Ankara, Turkey
  • +7 more
May 16, 2023

Phenylketonuria Trial (mRNA-3210)

Not yet recruiting
  • Phenylketonuria
  • (no location specified)
Nov 18, 2023

SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19 mRNA Vaccine (ZSVG-02-O)
  • COVID-19 Vaccine (Vero Cell) ,Inactivated
  • Dengfeng, Henan, China
  • +1 more
Nov 6, 2023

HIV-1-infection Trial in Kigali, Johannesburg (eOD-GT8 60mer mRNA Vaccine (100µg))

Active, not recruiting
  • HIV-1-infection
  • eOD-GT8 60mer mRNA Vaccine (100µg)
  • Kigali, Rwanda
  • +1 more
Sep 9, 2022

Respiratory Syncytial Virus Trial in United States (Placebo, mRNA-1345, Afluria® Quadrivalent)

Active, not recruiting
  • Respiratory Syncytial Virus
  • Placebo
  • +3 more
  • Birmingham, Alabama
  • +61 more
Dec 5, 2022

Hiv Trial in United States (V3G CH848 Pr-NP1 60mcg, 3M-052-AF 5mcg, Alum 500 mcg)

Not yet recruiting
  • Hiv
  • V3G CH848 Pr-NP1 60mcg
  • +5 more
  • Birmingham, Alabama
  • +5 more
Jun 5, 2023

Respiratory Syncytial Virus Trial in United States (Placebo, mRNA-1345)

Recruiting
  • Respiratory Syncytial Virus
  • Birmingham, Alabama
  • +269 more
Jan 30, 2023

Influenza Trial in United States (mRNA-1010, mRNA-1010.4, mRNA-1010.6)

Recruiting
  • Influenza
  • mRNA-1010
  • +2 more
  • Hollywood, Florida
  • +9 more
May 11, 2023

Influenza, Influenza Immunization Trial in United States (Influenza Hemagglutinin mRNA vaccine, Quadrivalent Recombinant

Completed
  • Influenza
  • Influenza Immunization
  • Influenza Hemagglutinin mRNA vaccine
  • Quadrivalent Recombinant Influenza Vaccine
  • Rolling Hills Estates, California
  • +19 more
Oct 31, 2023

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in United States

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • San Francisco, California
  • +5 more
Nov 1, 2023

Cytomegalovirus Trial in Canada, United Kingdom, United States (mRNA-1647, Placebo)

Recruiting
  • Cytomegalovirus
  • mRNA-1647
  • Placebo
  • La Mesa, California
  • +60 more
Jan 12, 2023

Healthy, Chronic Stable Illness Trial in United States (casirivimab+imdevimab, Moderna mRNA-1273 vaccine)

Completed
  • Healthy
  • Chronic Stable Illness
  • Little Rock, Arkansas
  • +5 more
Jan 9, 2023

Genital Herpes Trial in United States (mRNA-1608, BEXSERO)

Recruiting
  • Genital Herpes
  • mRNA-1608
  • BEXSERO
  • Birmingham, Alabama
  • +24 more
Sep 11, 2023

Papillomavirus Infections, Coronavirus Disease (COVID-19) Trial in United States (9vHPV Vaccine, mRNA-1273 Vaccine)

Recruiting
  • Papillomavirus Infections
  • Coronavirus Disease (COVID-19)
  • 9vHPV Vaccine
  • mRNA-1273 Vaccine
  • Phoenix, Arizona
  • +37 more
Jan 18, 2023

SARS-CoV-2 Trial in Atlanta, Seattle (mRNA-1273)

Active, not recruiting
  • SARS-CoV-2
  • mRNA-1273
  • Mesa, Arizona
  • +14 more
Aug 31, 2022

COVID Vaccine Immunity in Kidney Transplant Recipients

Withdrawn
  • End Stage Renal Disease
  • Kidney Transplant; Complications
  • Coronavirus (COVID-19) SARS-CoV-2 inSIGHT™ T Cell Immunity Test
  • (no location specified)
Oct 25, 2022

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)

Not yet recruiting
  • Angiosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 23, 2023

Seasonal Influenza Trial in Argentina, Australia, Colombia (mRNA-1010, Licensed quadrivalent inactivated seasonal influenza

Active, not recruiting
  • Seasonal Influenza
  • mRNA-1010
  • Licensed quadrivalent inactivated seasonal influenza vaccine
  • Buenos Aires, Argentina
  • +52 more
Sep 19, 2022